TrialInternational journal of clinical practice2014

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder.

K-D Sievert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.